Filing Details

Accession Number:
0001144204-16-089643
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-22 18:38:21
Reporting Period:
2016-03-22
Filing Date:
2016-03-22
Accepted Time:
2016-03-22 18:38:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1012477 Flamel Technologies Sa FLML Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1661781 T. Phillandas Thompson 33 Avenue Du Dr. Georges Levy
Venissieux I0 69200
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Adss Acquisiton 2016-03-22 10,000 $11.10 20,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Adss Stock Option (right to buy) $7.36 2023-12-12 100,000 100,000 Direct
Adss Stock Option (right to buy) $16.30 2024-12-11 95,000 95,000 Direct
Adss Stock Option (right to buy) $14.35 2025-12-10 100,000 100,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2023-12-12 100,000 100,000 Direct
2024-12-11 95,000 95,000 Direct
2025-12-10 100,000 100,000 Direct
Footnotes
  1. The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value 0.122 Euros per share, of the issuer; ADSs are represented by American Depositary Receipts.
  2. 10,000 are Restricted ADSs granted under the issuer's "Free Shares" award program on 12/11/2014. All of such 10,000 restricted ADSs will vest and be issued to the reporting person on the fourth anniversary of the grant date, provided that the reporting person continues to be employed by the issuer or an affiliate thereof on that date.
  3. Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/12/2013 grant date.
  4. Options become exercisable as to 23,750 ADSs on each of the first four anniversaries after the 12/11/2014 grant date.
  5. Options become exercisable as to 25,000 ADSs on each of the first four anniversaries after the 12/10/2015 grant date.